Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 174 results found. Search for [ Bayer ]

Results 100 to 120 of 174
Reuters
Mumbai, September 7, 2015
Pfizer is reviewing its options for further action, a Mumbai-based company spokesman said in an emailed statement.


PTI
New York, July 29, 2015
The companies had filed a case against Glenmark in 2013 after it had filled an Abbreviated New Drug Application seeking to market a generic azelaic acid hydrogel in 2012.


BT Online Bureau
New Delhi, July 28, 2015
The benchmark NSE Nifty had ended below the 8,400 level on Monday down 160.55 points at 8361 while the 30-share BSE Sensex plunged 550.93 points to 27,561.38.


E. Kumar Sharma
July 5, 2015
Staying close to its farmer-consumer, anticipating demand and taking risks to provide for it, are the hallmarks of G.V. Bhaskar Rao-led company.


PTI
New Delhi, June 4, 2015
The company has appointed Ambit Corporate Finance as the lead manager to the buyback offer.


PB Jayakumar
May 22, 2015
About 20-30 per cent cases of infertility are related to 'secondary infertility' of the general infertility population, the study says.


E Kumar Sharma
May 16, 2015
For, if the current order is any indication, it is not as if application of patent law has any domestic industry bias or that effective judicial remedy is not available.


IANS
Ahmedabad, March 11, 2015
The aircraft has been built not just to fly around the world but also carry a message demonstrating effectiveness of clean technologies and importance of sustainability.


P.B. Jayakumar
March 5, 2015
The US is mounting pressure on India to agree to its terms in pharma IP protection. How long can India resist?


www.businesstoday.in
February 13, 2015
Gadgets and Gizmos tells you about the newest gadgets and technology in the market and what these offer.


E Kumar Sharma
January 17, 2015
The Indo-US talks in January, to be held just days before President Barack Obama visits India to attend the Republic Day celebrations, are part of a work plan on IPR agreed upon by both nations in November.


E Kumar Sharma
December 18, 2014
Experts say the Novartis-Cipla case raises similar issues that previous cases did - non-availability of drugs, non-working of patent in India and unaffordable pricing.


Tanvi Varma
November 21, 2014
The markets have been getting strong support from foreign institutional investors, or FIIs, who pumped in Rs 5,700 crore this week despite the rupee weakening by 2.5 per cent.


Abhishek Vishnoi
Mumbai, November 12, 2014
The stock was headed towards its biggest single-day gain since August 2014 after Bayer's profit for the September-quarter rose by 51 per cent to Rs 176 crore.


E Kumar Sharma
August 30, 2014
The technology provider, which has provisional turnover of Rs 25 crore, offers IT solutions to agribusiness companies and farmers alike.


Manoj Kumar
May 1, 2014
Commerce Secretary Rajeev Kher praised a decision by the US Trade Representative not to label India with its worst offender tag in an annual scorecard on protecting U.S. patents, copyrights and other intellectual property.


PTI
New Delhi, April 26, 2014
With this acquisition, EID Parry would ensure reliable sourcing of Astaxanthin for its subsidiary US Nutraceuticals LLC (Valensa). The entire production of Alimtec will be used by Valensa for its Astaxanthin products catering to US and Europe markets, the filing added.


Mail Today Bureau
New Delhi, March 24, 2014
Commerce and industry minister Anand Sharma on Sunday came out strongly to defend India's track record on intellectual property rights and said that the country is ready to take on the US at the World Trade Organization (WTO) over the issue.


Bill Berkrot
February 8, 2014
The US Chamber of Commerce has requested that India be classified as a Priority Foreign Country, a tag given to the worst offenders when it comes to protecting intellectual property and one that could trigger trade sanctions.


Sumeet Chatterjee and Ben Hirschler
Mumbai/London, February 6, 2014
Global pharmaceutical firms are pressuring the United States to act against India to stop more local companies producing up to a dozen new varieties of cheap generic drugs still on-patent.


PAGES 6 OF 9  6789